Hubbell (HUBB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors often find it ...

Shares of Ardelyx (ARDX) have gained 3.6% over the past four weeks to close the last trading session at $6.09, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.7 indicates a potential upside of 92.1%.The average comprises 10 short-term price targets ranging from a low of $8.00 to a high of $16.00, with a standard deviation of $2.71. While the lowest estimate indicates an incr ...

Dutch Bros (BROS) closed the last trading session at $60.12, gaining 3.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $77.61 indicates a 29.1% upside potential.The mean estimate comprises 18 short-term price targets with a standard deviation of $7.62. While the lowest estimate of $63.00 indicates a 4.8% increase from the current price level, the most optimistic analyst expects ...

Cactus, Inc. (WHD) shares soared 5.7% in the last trading session to close at $49.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.2% gain over the past four weeks.Cactus' shares rallied on the last trading day as investor sentiment strengthened following its agreement to acquire a 65% stake in Baker Hughes’ Surface Pressure Control business. The transaction expands Cactus’ global footprint and customer base while providing ...

Core Viewpoint - Oceaneering International's stock experienced a significant increase of 5.3% to close at $26.17, driven by strong trading volume and rising oil prices due to geopolitical tensions in Venezuela [1][2]. Group 1: Stock Performance - Oceaneering International's shares rose 5.3% in the last trading session, contrasting with a 7.8% loss over the previous four weeks [1]. - The stock's recent performance is attributed to heightened oil prices following geopolitical instability in Venezuela, particularly the capture of President Nicolás Maduro by U.S. forces [2]. Group 2: Earnings Expectations - The company is projected to report quarterly earnings of $0.43 per share, reflecting a year-over-year increase of 16.2%, while revenues are expected to be $711 million, a slight decrease of 0.3% from the previous year [3]. - The consensus EPS estimate for Oceaneering International has remained unchanged over the last 30 days, indicating a potential lack of momentum in earnings estimate revisions [4]. Group 3: Industry Context - Oceaneering International is part of the Zacks Oil and Gas - Field Services industry, which is currently experiencing upward pressure on stock prices due to stable OPEC+ output levels and geopolitical factors affecting oil supply [2][5]. - Another company in the same industry, Helix Energy, saw a 5.8% increase in its stock price, although it has faced a -12.7% return over the past month [5].

Core Viewpoint - Marathon Petroleum's stock experienced a significant rally of 5.9% to close at $174.94, following a notable increase in trading volume, despite a previous loss of 13.3% over the past four weeks [1] Group 1: Stock Performance and Market Influences - The rise in Marathon Petroleum's stock price was influenced by a slight increase in oil prices to $58.32 per barrel, following the capture of Venezuelan President Nicolás Maduro, which raised investor sentiment [2] - OPEC+ maintained its oil production plans, alleviating concerns about oil supply, which further contributed to the positive sentiment around Marathon Petroleum [2] Group 2: Earnings Expectations - The company is projected to report quarterly earnings of $3.73 per share, reflecting a substantial year-over-year increase of 384.4%, while revenues are expected to decline by 8.6% to $30.58 billion [3] - Recent trends indicate that the consensus EPS estimate for Marathon Petroleum has been revised 3.9% lower over the last 30 days, which typically does not correlate with price appreciation [4] Group 3: Industry Context - Marathon Petroleum holds a Zacks Rank of 2 (Buy) within the Oil and Gas - Refining and Marketing industry, indicating a favorable outlook compared to other stocks in the sector [5] - Another company in the same industry, Valvoline, has a Zacks Rank of 5 (Strong Sell), highlighting a contrasting performance within the sector [6]

Core Viewpoint - Nov Inc. (NOV) shares experienced a significant increase of 6.5% to $17.48, driven by a rise in WTI crude oil prices and positive market sentiment regarding supply stability [1][2]. Group 1: Stock Performance - NOV shares ended the last trading session at $17.48, marking a 6.5% increase with higher-than-average trading volume [1]. - The stock has gained 1.5% over the past four weeks, indicating a positive trend [1]. Group 2: Market Influences - The surge in NOV shares was influenced by a rebound in WTI crude oil prices, which stabilized after concerns about global supply [2]. - The U.S. capture of Venezuelan President Nicolás Maduro contributed to the stabilization of oil supply concerns, impacting NOV positively [2]. - OPEC+ has committed to maintaining steady output through the first quarter, further supporting the outlook for higher energy prices [2]. Group 3: Earnings Expectations - NOV is expected to report quarterly earnings of $0.25 per share, reflecting a year-over-year decline of 39% [3]. - Revenue projections for NOV stand at $2.17 billion, which is a decrease of 5.9% compared to the same quarter last year [3]. - The consensus EPS estimate for NOV has remained unchanged over the last 30 days, suggesting a lack of momentum in earnings revisions [4]. Group 4: Industry Context - NOV is part of the Zacks Oil and Gas - Mechanical and Equipment industry, which includes other companies like Forum Energy Technologies (FET) [5]. - FET's stock increased by 3.3% to $39.51, with a return of 8.6% over the past month, indicating a positive trend within the industry [5][6].

Group 1 - Chevron's shares increased by 5.1% to $163.85, with a higher-than-average trading volume, compared to a 3.9% gain over the past four weeks [1] - The stock's rise is attributed to optimism regarding potential expanded operations in Venezuela following recent U.S. actions involving President Nicolás Maduro, positioning Chevron uniquely in the market [2] - Chevron currently produces about 200,000 barrels per day from its Venezuelan joint ventures, supported by a U.S. Office of Foreign Assets Control license since 2022 [2] Group 2 - The upcoming quarterly earnings report for Chevron is expected to show earnings of $1.54 per share, reflecting a year-over-year decline of 25.2%, while revenues are projected at $53.61 billion, a 2.7% increase from the previous year [3] - The consensus EPS estimate for Chevron has been revised down by 7.2% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] - Chevron holds a Zacks Rank of 3 (Hold), indicating a neutral outlook, while another company in the same industry, Petrobras, has also maintained a Zacks Rank of 3 [5][6]

Core & Main (CNM) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.Analysts' growing optimism on the earnings prospects of this distributor of water and fire protection products is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estim ...

Investors might want to bet on Vivos Therapeutics, Inc. (VVOS) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The pow ...